Table 1.

Baseline characteristicsa

CharacteristicHCV Negative(n = 23,854)HCV Positive(n = 1928)
Age (yr; mean [SD])58 (14)53 (9)
Race (n [%])b
    white13,428 (56)1152 (60)
    black2801 (12)308 (16)
    other852 (4)53 (3)
    unknown6773 (28)415 (22)
Male gender (n [%])21,620 (91)1842 (96)
Diabetes (n [%])5176 (22)357 (19)
Hypertension (n [%])16,417 (69)1175 (61)
Coronary artery disease (n [%])5462 (23)286 (15)
SBP (mmHg; n [%])c
    <1201978 (10)198 (14)
    120 to 1397825 (41)587 (42)
    140 to 1597086 (37)467 (33)
    ≥160 mmHg2252 (12)161 (11)
DBP (mmHg; n [%])d
    <8010,793 (56)662 (47)
    80 to 896057 (32)484 (34)
    90 to 991888 (10)223 (16)
    ≥100402 (2)45 (3)
BMI (kg/m2; n [%])e
    <18.592 (<1)12 (1)
    18.5 to 24.93326 (18)335 (26)
    25.0 to 29.96677 (37)502 (38)
    ≥30.08150 (45)458 (35)
ALT (U/L; mean [SD])31 (29)71 (85)
ALT (n [%])f
    0 to 399036 (80)424 (40)
    ≥402195 (20)631 (60)
Albumin (g/dl; n [%])f
    <3.5164 (2)58 (8)
    ≥3.5 to 5.26785 (98)712 (92)
  • a BMI, body mass index; DBP, diastolic BP; HCV, hepatitis C virus; SBP, systolic BP.

  • b After multiple imputation, on average, the distribution of race in HCV-negative patients was white 79%, black 16%, and other 5% and in HCV-positive patients was white 76%, black 20%, and other 4%.

  • c Time-averaged outpatient SBP and

  • d time-averaged outpatient DBP for 18-mo interval before antibody test for patients with documented BP. Total number reflects number of patients with outpatient BP measured at least once.

  • e BMI defined by time-averaged outpatient weight for 18-mo interval before antibody test divided by height for patients with both height and weight measured.

  • f Time-averaged outpatient laboratory values for 18-mo interval before antibody test for patients. Total number reflects number of patients with specific outpatient laboratory values measured at least once.